Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PODD
- Price
- 280.00
- Stock movement down
- -4.96 (-1.74%)
- Company name
- Insulet Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 19.70B
- Ent value
- 20.58B
- Price/Sales
- 7.81
- Price/Book
- 14.23
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 80.00
- Forward P/E
- 45.28
- PEG
- -
- EPS growth
- 97.96%
- 1 year return (CAGR)
- 1.42%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PODD does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 80.00 |
| Price to OCF | 36.91 |
| Price to FCF | 46.76 |
| Price to EBITDA | 43.66 |
| EV to EBITDA | 45.62 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.81 |
| Price to Book | 14.23 |
| EV to Sales | 8.16 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 70.35M |
| EPS (TTM) | 3.48 |
| FCF per share (TTM) | 5.96 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.52B |
| Gross profit (TTM) | 1.80B |
| Operating income (TTM) | 436.90M |
| Net income (TTM) | 246.20M |
| EPS (TTM) | 3.48 |
| EPS (1y forward) | 6.18 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 71.46% |
| Operating margin (TTM) | 17.32% |
| Profit margin (TTM) | 9.76% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 757.40M |
| Net receivables | 462.20M |
| Total current assets | 1.86B |
| Goodwill | 51.60M |
| Intangible assets | 105.00M |
| Property, plant and equipment | 0.00 |
| Total assets | 3.03B |
| Accounts payable | 48.20M |
| Short/Current long term debt | 1.03B |
| Total current liabilities | 647.70M |
| Total liabilities | 1.65B |
| Shareholder's equity | 1.38B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 533.70M |
| Capital expenditures (TTM) | 112.50M |
| Free cash flow (TTM) | 421.20M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 17.79% |
| Return on Assets | 8.13% |
| Return on Invested Capital | 10.19% |
| Cash Return on Invested Capital | 17.44% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 284.96 |
| Daily high | 287.41 |
| Daily low | 275.12 |
| Daily Volume | 1.31M |
| All-time high | 352.82 |
| 1y analyst estimate | 377.72 |
| Beta | 1.38 |
| EPS (TTM) | 3.48 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| PODD | S&P500 | |
| Current price drop from All-time high | -20.64% | -0.89% |
| Highest price drop | -30.61% | -19.00% |
| Date of highest drop | 17 Oct 2024 | 8 Apr 2025 |
| Avg drop from high | -14.47% | -2.49% |
| Avg time to new high | 36 days | 6 days |
| Max time to new high | 215 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
19.70B
Marketcap category
Large-cap
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Employees
3900
Website
Investor relations
-
SEC filings
CEO
Shacey Petrovic
Country
USA
City
Acton
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page